Kajal P Patel, MD
Nephrology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location · Valley Medical Consultants Inc · 5 clinicians in this group
Looking this up.
Hospitals listed: 052514 · 052572 · 052891 · 552652 · 552714 · El Camino Health · Good Samaritan Hospital · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patel’s office at (408) 223-7474 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93552 · Current
Licensed to practise in California · since 2005 · expires 2027-08-31 · Sardar Patel University, Pramukhswami Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$310,945
Medicare paid this office $310,945 for 637 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $115,828 | $323 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 303 | $88,745 | $70 |
| Short return visit (20+ min) | 249 | $37,139 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 223 | $28,922 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $15,550 | $264 |
See all 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $115,828 | $323 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 303 | $88,745 | $70 |
| Short return visit (20+ min) | 249 | $37,139 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 223 | $28,922 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $15,550 | $264 |
| New patient visit (45+ min) | 49 | $6,305 | $129 |
Who their Medicare patients are
637 Original Medicare patients in 2024. Average age 77 · Under 65 12% · 85 and older 26% · Women 54% · Also on Medicaid 66% · Health risk score 4.28. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 71% · Heart failure 49% · Coronary heart disease 48% · Atrial fibrillation 36% · Dementia 23% · Depression 22% · COPD 20% · Stroke 18% · Cancer 13%.
The office billed $935,880, Medicare allowed $403,499 and paid $310,945; for 2,696 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 637 | 2,696 | 77 | 4.28 | $935,880 | $310,945 |
| 2023 | 653 | 3,001 | 76 | 4.31 | $1,045,005 | $355,428 |
| 2022 | 658 | 2,833 | 75 | 4.18 | $942,804 | $345,726 |
| 2021 | 608 | 2,687 | 74 | 4.37 | $769,805 | $358,992 |
| 2020 | 593 | 2,910 | 75 | 4.42 | $763,520 | $350,499 |
| 2019 | 668 | 3,382 | 74 | 4.60 | $650,469 | $368,636 |
| 2018 | 564 | 3,192 | 73 | 4.86 | $623,508 | $337,021 |
| 2017 | 511 | 2,787 | 73 | 4.82 | $550,260 | $399,992 |
| 2016 | 463 | 2,402 | 74 | 4.46 | $352,241 | $173,364 |
| 2015 | 462 | 2,170 | 75 | 4.21 | $301,578 | $155,021 |
| 2014 | 461 | 2,128 | 75 | 3.67 | $281,554 | $155,140 |
| 2013 | 490 | 2,367 | 74 | 3.71 | $327,720 | $191,398 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 49 | $133,300 | $331 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 348 | $108,216 | $73 |
| Short return visit (20+ min) | 226 | $33,163 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 246 | $33,029 | $119 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $14,072 | $276 |
| New patient visit (45+ min) | 58 | $7,585 | $131 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $4,613 | $192 |
2022: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 59 | $147,198 | $337 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 347 | $92,889 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 255 | $33,906 | $123 |
| Short return visit (20+ min) | 194 | $26,588 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $10,642 | $280 |
| New patient visit (45+ min) | 60 | $8,277 | $138 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $5,067 | $195 |
2021: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 56 | $168,041 | $337 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 333 | $84,514 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 241 | $34,697 | $125 |
| Short return visit (20+ min) | 166 | $31,841 | $77 |
| New patient visit (45+ min) | 64 | $8,608 | $134 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $8,141 | $281 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $503 | $20 |
2020: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 63 | $160,276 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 340 | $107,210 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 210 | $31,631 | $130 |
| Short return visit (20+ min) | 159 | $20,013 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $6,585 | $227 |
| Hemodialysis procedure with physician evaluation | 30 | $2,517 | $68 |
| New patient visit (45+ min) | 17 | $2,183 | $128 |
2019: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 57 | $144,276 | $262 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 346 | $108,010 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 256 | $38,171 | $124 |
| Short return visit (20+ min) | 215 | $33,744 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $10,250 | $218 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $7,417 | $172 |
| New patient visit (45+ min) | 50 | $7,375 | $147 |
| Hemodialysis procedure with physician evaluation | 71 | $5,698 | $66 |
| Return visit (30+ min) | 18 | $1,696 | $94 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $301 | $17 |
2018: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $133,544 | $251 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 315 | $97,852 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 216 | $34,018 | $118 |
| Short return visit (20+ min) | 181 | $29,738 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $12,274 | $212 |
| Hemodialysis procedure with physician evaluation | 78 | $6,803 | $63 |
| New patient visit (45+ min) | 45 | $6,535 | $145 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $4,455 | $165 |
| Return visit (30+ min) | 11 | $1,160 | $97 |
2017: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 60 | $161,986 | $337 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 266 | $104,850 | $85 |
| Short return visit (20+ min) | 178 | $43,863 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 187 | $38,035 | $160 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $16,766 | $284 |
| New patient visit (45+ min) | 36 | $6,601 | $183 |
| Hemodialysis procedure with physician evaluation | 45 | $5,648 | $84 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 266 | $77,780 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 200 | $33,835 | $121 |
| Short return visit (20+ min) | 153 | $28,454 | $61 |
| Hemodialysis procedure with physician evaluation | 124 | $19,204 | $64 |
| New patient visit (45+ min) | 44 | $5,942 | $135 |
| Return visit (30+ min) | 12 | $1,133 | $94 |
| Hospital discharge day management, 30 minutes or less | 12 | $855 | $66 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 244 | $68,553 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 187 | $31,715 | $122 |
| Short return visit (20+ min) | 169 | $27,410 | $61 |
| Hemodialysis procedure with physician evaluation | 89 | $11,603 | $64 |
| New patient visit (45+ min) | 40 | $5,563 | $139 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $3,404 | $35 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,790 | $66 |
2014: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 232 | $62,385 | $64 |
| Short return visit (20+ min) | 170 | $28,859 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $18,527 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 118 | $16,674 | $122 |
| Hemodialysis procedure with physician evaluation | 80 | $10,777 | $65 |
| New patient visit (45+ min) | 35 | $4,939 | $141 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $3,366 | $35 |
| Return visit (30+ min) | 26 | $2,213 | $85 |
| Hospital discharge day management, 30 minutes or less | 30 | $2,030 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,653 | $92 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 242 | $61,292 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 174 | $37,394 | $176 |
| Short return visit (20+ min) | 166 | $24,179 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $21,335 | $90 |
| Hemodialysis procedure with physician evaluation | 89 | $13,820 | $63 |
| Return visit (30+ min) | 81 | $13,688 | $94 |
| New patient visit (45+ min) | 49 | $7,001 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $5,585 | $119 |
| Hospital discharge day management, 30 minutes or less | 50 | $3,535 | $64 |
Medicaid work
$40,727 in 2024
Medicaid paid $40,727 for 1,925 billed services this clinician did in 2024, up to 58 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 317 | $18,333 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,070 | $13,749 |
| Short return visit (20+ min) | 348 | $4,261 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 38 | $2,231 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 152 | $2,153 |
| 2024 | 1,925 | 5 | 58 | $40,727 |
| 2023 | 3,117 | 5 | 66 | $66,888 |
| 2022 | 2,595 | 4 | 56 | $56,316 |
| 2021 | 2,441 | 5 | 69 | $55,270 |
| 2020 | 2,199 | 4 | 56 | $32,797 |
| 2019 | 743 | 4 | 29 | $12,513 |
| 2018 | 223 | 3 | 22 | $2,870 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 485 | $35,253 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,849 | $19,625 |
| Short return visit (20+ min) | 469 | $5,340 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 262 | $4,548 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 52 | $2,121 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 423 | $27,211 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,604 | $20,326 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 222 | $5,392 |
| Short return visit (20+ min) | 346 | $3,386 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 390 | $27,747 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,428 | $18,699 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 268 | $6,133 |
| Short return visit (20+ min) | 343 | $2,691 |
| New patient visit (45+ min) | 12 | $0 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,400 | $14,354 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 351 | $11,681 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 213 | $4,553 |
| Short return visit (20+ min) | 235 | $2,209 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 548 | $9,201 |
| Short return visit (20+ min) | 144 | $1,632 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 39 | $1,042 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 12 | $637 |
2018
| Short return visit (20+ min) | 88 | $1,321 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 122 | $933 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $616 |
Drugs they prescribed that Part D paid
$692,208
Pharmacies billed $692,208 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,226) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
2,487 generic and 739 brand-name prescriptions · $692,208 in drug cost · 34 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 275 | $292,921 | $1,065 |
| Velphoro | 16 | $82,147 | $5,134 |
| Veltassa | 71 | $50,989 | $718 |
| Lokelma | 45 | $30,360 | $675 |
| Sevelamer Carbonate | 90 | $26,869 | $299 |
See all 42 drugs
| Jardiance | 275 | $292,921 | $1,065 |
| Velphoro | 16 | $82,147 | $5,134 |
| Veltassa | 71 | $50,989 | $718 |
| Lokelma | 45 | $30,360 | $675 |
| Sevelamer Carbonate | 90 | $26,869 | $299 |
| Kerendia | 29 | $24,439 | $843 |
| Auryxia | 12 | $23,580 | $1,965 |
| Procrit | 42 | $22,164 | $528 |
| Prosol | 94 | $14,616 | $155 |
| Clinolipid | 24 | $10,437 | $435 |
| Calcium Acetate | 40 | $5,812 | $145 |
| Losartan | 361 | $4,145 | $11 |
| Allopurinol | 172 | $4,134 | $24 |
| Retacrit | 15 | $3,594 | $240 |
| Furosemide | 386 | $2,944 | $8 |
| Amlodipine Besylate | 349 | $2,159 | $6 |
| Hydralazine | 108 | $2,001 | $19 |
| Sps | 38 | $1,946 | $51 |
| Cinacalcet | 33 | $1,943 | $59 |
| Bumetanide | 33 | $1,937 | $59 |
| Omega-3 Acid Ethyl Esters | 14 | $1,404 | $100 |
| Valsartan | 33 | $1,365 | $41 |
| Metoprolol | 71 | $1,123 | $16 |
| Carvedilol | 96 | $866 | $9 |
| Fludrocortisone Acetate | 14 | $667 | $48 |
| Diltiazem 24hr Er (Cd) | 22 | $605 | $28 |
| Calcitriol | 96 | $564 | $6 |
| Rosuvastatin | 17 | $550 | $32 |
| Atorvastatin | 59 | $509 | $9 |
| Lactulose | 34 | $500 | $15 |
| Lisinopril | 45 | $443 | $10 |
| Metoprolol | 57 | $427 | $7 |
| Pantoprazole | 36 | $427 | $12 |
| Potassium Chloride | 19 | $423 | $22 |
| Famotidine | 23 | $198 | $9 |
| Lidocaine-Prilocaine | 15 | $191 | $13 |
| Gabapentin | 15 | $124 | $8 |
| Prazosin | 15 | $120 | $8 |
| Simvastatin | 15 | $110 | $7 |
| Hydrochlorothiazide | 13 | $103 | $8 |
| Spironolactone | 13 | $72 | $6 |
| Levofloxacin | 18 | $46 | $3 |
Year by year
| 2024 | 3,226 | 463 | 0% (0) | 23% | $692,208 |
| 2023 | 2,759 | 405 | None | None | $609,508 |
| 2022 | 2,445 | 375 | None | None | $467,638 |
| 2021 | 2,209 | 298 | 1% (13) | 17% | $401,720 |
| 2020 | 2,485 | 271 | None | None | $399,418 |
| 2019 | 2,628 | 297 | 1% (12) | None | $499,833 |
| 2018 | 2,462 | 293 | 1% (17) | None | $554,243 |
| 2017 | 2,333 | 265 | 1% (21) | 27% | $710,172 |
| 2016 | 2,323 | 268 | 1% (15) | None | $589,607 |
| 2015 | 2,014 | 268 | 1% (13) | None | $416,474 |
| 2014 | 1,983 | 235 | 1% (11) | None | $301,400 |
| 2013 | 1,782 | 229 | None | None | $212,917 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Jardiance | 138 | $194,249 | $1,408 |
| Sevelamer Carbonate | 93 | $75,982 | $817 |
| Renvela | 17 | $68,935 | $4,055 |
| Veltassa | 53 | $52,015 | $981 |
| Lokelma | 40 | $28,879 | $722 |
| Kerendia | 26 | $25,443 | $979 |
| Procrit | 29 | $12,559 | $433 |
| Prosol | 75 | $11,849 | $158 |
| Cinacalcet | 22 | $9,392 | $427 |
| Farxiga | 11 | $8,797 | $800 |
| Clinolipid | 18 | $8,180 | $454 |
| Losartan | 355 | $7,079 | $20 |
| Calcium Acetate | 39 | $5,727 | $147 |
| Allopurinol | 141 | $5,548 | $39 |
| Furosemide | 351 | $4,027 | $11 |
| Hydralazine | 128 | $3,960 | $31 |
| Amlodipine Besylate | 253 | $3,551 | $14 |
| Bumetanide | 20 | $2,468 | $123 |
| Omega-3 Acid Ethyl Esters | 18 | $2,187 | $121 |
| Midodrine | 14 | $1,955 | $140 |
| Clonidine | 11 | $1,629 | $148 |
| Atorvastatin | 60 | $1,458 | $24 |
| Calcitriol | 121 | $1,350 | $11 |
| Carvedilol | 96 | $1,339 | $14 |
| Potassium Chloride | 27 | $1,212 | $45 |
| Valsartan | 19 | $1,168 | $61 |
| Metoprolol | 41 | $1,006 | $25 |
| Rosuvastatin | 12 | $892 | $74 |
| Famotidine | 27 | $785 | $29 |
| Metoprolol | 52 | $722 | $14 |
| Tamsulosin | 15 | $704 | $47 |
| Pantoprazole | 22 | $656 | $30 |
| Levothyroxine | 14 | $653 | $47 |
| Lactulose | 28 | $643 | $23 |
| Labetalol | 11 | $630 | $57 |
| Gabapentin | 17 | $572 | $34 |
| Sps | 12 | $572 | $48 |
| Fludrocortisone Acetate | 14 | $539 | $38 |
| Lisinopril | 39 | $516 | $13 |
| Prazosin | 16 | $231 | $14 |
| Clonidine | 12 | $207 | $17 |
| Lidocaine-Prilocaine | 15 | $203 | $14 |
| Lovastatin | 12 | $196 | $16 |
| Prednisone | 13 | $181 | $14 |
| Glimepiride | 15 | $139 | $9 |
| Levofloxacin | 21 | $45 | $2 |
2022: 42 drugs
| Renvela | 27 | $117,288 | $4,344 |
| Sevelamer Carbonate | 106 | $76,731 | $724 |
| Auryxia | 15 | $29,365 | $1,958 |
| Clinolipid | 78 | $21,747 | $279 |
| Jardiance | 15 | $17,960 | $1,197 |
| Lokelma | 17 | $14,589 | $858 |
| Kerendia | 15 | $14,588 | $973 |
| Procrit | 13 | $6,487 | $499 |
| Cinacalcet | 13 | $6,180 | $475 |
| Calcium Acetate | 41 | $5,705 | $139 |
| Veltassa | 17 | $5,278 | $310 |
| Demeclocycline | 11 | $4,635 | $421 |
| Prosol | 35 | $4,631 | $132 |
| Midodrine | 22 | $4,574 | $208 |
| Losartan | 276 | $4,132 | $15 |
| Hydralazine | 137 | $3,274 | $24 |
| Furosemide | 321 | $3,160 | $10 |
| Amlodipine Besylate | 233 | $2,414 | $10 |
| Allopurinol | 121 | $1,869 | $15 |
| Labetalol | 23 | $1,678 | $73 |
| Potassium Chloride | 26 | $1,516 | $58 |
| Atorvastatin | 88 | $1,351 | $15 |
| Omega-3 Acid Ethyl Esters | 12 | $1,287 | $107 |
| Metoprolol | 66 | $1,223 | $19 |
| Gabapentin | 32 | $1,043 | $33 |
| Valsartan | 15 | $1,036 | $69 |
| Carvedilol | 66 | $908 | $14 |
| Calcitriol | 84 | $823 | $10 |
| Lisinopril | 42 | $679 | $16 |
| Metoprolol | 41 | $671 | $16 |
| Megestrol Acetate | 12 | $644 | $54 |
| Pantoprazole | 27 | $533 | $20 |
| Famotidine | 17 | $530 | $31 |
| Lidocaine-Prilocaine | 16 | $478 | $30 |
| Lactulose | 16 | $340 | $21 |
| Glimepiride | 20 | $257 | $13 |
| Lovastatin | 16 | $252 | $16 |
| Clonidine | 18 | $236 | $13 |
| Tamsulosin | 11 | $176 | $16 |
| Omeprazole | 13 | $161 | $12 |
| Spironolactone | 13 | $150 | $12 |
| Simvastatin | 12 | $83 | $7 |
2021: 44 drugs
| Renvela | 32 | $116,353 | $3,636 |
| Sevelamer Carbonate | 118 | $42,791 | $363 |
| Auryxia | 16 | $31,776 | $1,986 |
| Clinolipid | 101 | $26,755 | $265 |
| Aranesp | 17 | $14,189 | $835 |
| Januvia | 11 | $14,004 | $1,273 |
| Lokelma | 21 | $11,221 | $534 |
| Demeclocycline | 15 | $8,694 | $580 |
| Calcium Acetate | 55 | $7,407 | $135 |
| Midodrine | 28 | $6,364 | $227 |
| Febuxostat | 18 | $5,700 | $317 |
| Clinisol | 38 | $5,637 | $148 |
| Clonidine | 25 | $4,304 | $172 |
| Hydralazine | 129 | $2,844 | $22 |
| Furosemide | 250 | $2,586 | $10 |
| Losartan | 171 | $2,234 | $13 |
| Omega-3 Acid Ethyl Esters | 19 | $1,982 | $104 |
| Allopurinol | 125 | $1,850 | $15 |
| Amlodipine Besylate | 188 | $1,762 | $9 |
| Potassium Chloride | 29 | $1,317 | $45 |
| Metoprolol | 51 | $1,200 | $24 |
| Sps | 14 | $1,029 | $73 |
| Ventolin Hfa | 11 | $1,024 | $93 |
| Atorvastatin | 69 | $946 | $14 |
| Gabapentin | 28 | $870 | $31 |
| Labetalol | 15 | $767 | $51 |
| Carvedilol | 51 | $751 | $15 |
| Retacrit | 14 | $630 | $45 |
| Calcitriol | 58 | $622 | $11 |
| Metoprolol | 52 | $563 | $11 |
| Lidocaine-Prilocaine | 16 | $499 | $31 |
| Hydrocodone-Acetaminophen | 13 | $413 | $32 |
| Pantoprazole | 14 | $354 | $25 |
| Famotidine | 14 | $297 | $21 |
| Pravastatin | 12 | $281 | $23 |
| Glimepiride | 29 | $280 | $10 |
| Lactulose | 21 | $273 | $13 |
| Lisinopril | 21 | $221 | $11 |
| Clonidine | 15 | $202 | $13 |
| Lovastatin | 13 | $161 | $12 |
| Glipizide | 16 | $123 | $8 |
| Prednisone | 12 | $115 | $10 |
| Simvastatin | 11 | $77 | $7 |
| Atenolol | 11 | $61 | $6 |
2020: 46 drugs
| Renvela | 40 | $145,859 | $3,646 |
| Sevelamer Carbonate | 132 | $43,052 | $326 |
| Auryxia | 19 | $23,221 | $1,222 |
| Januvia | 18 | $16,886 | $938 |
| Clinisol | 117 | $16,825 | $144 |
| Veltassa | 26 | $15,878 | $611 |
| Aranesp | 13 | $10,414 | $801 |
| Febuxostat | 26 | $9,334 | $359 |
| Vascepa | 15 | $8,551 | $570 |
| Demeclocycline | 13 | $6,645 | $511 |
| Intralipid | 49 | $6,619 | $135 |
| Spiriva | 13 | $6,305 | $485 |
| Midodrine | 41 | $6,286 | $153 |
| Procrit | 13 | $6,206 | $477 |
| Calcium Acetate | 51 | $6,118 | $120 |
| Clinolipid | 20 | $4,298 | $215 |
| Prosol | 35 | $3,562 | $102 |
| Hydralazine | 137 | $2,982 | $22 |
| Potassium Chloride | 37 | $2,945 | $80 |
| Furosemide | 247 | $2,133 | $9 |
| Losartan | 153 | $1,672 | $11 |
| Omega-3 Acid Ethyl Esters | 15 | $1,606 | $107 |
| Allopurinol | 123 | $1,469 | $12 |
| Amlodipine Besylate | 199 | $1,378 | $7 |
| Ventolin Hfa | 18 | $1,111 | $62 |
| Calcitriol | 62 | $1,011 | $16 |
| Metoprolol | 37 | $961 | $26 |
| Carvedilol | 72 | $821 | $11 |
| Valsartan | 13 | $815 | $63 |
| Sps | 11 | $796 | $72 |
| Atorvastatin | 63 | $766 | $12 |
| Gabapentin | 51 | $766 | $15 |
| Clonidine | 27 | $587 | $22 |
| Metoprolol | 54 | $431 | $8 |
| Glimepiride | 47 | $421 | $9 |
| Pantoprazole | 29 | $369 | $13 |
| Pravastatin | 19 | $363 | $19 |
| Tamsulosin | 23 | $357 | $16 |
| Lisinopril | 46 | $341 | $7 |
| Sertraline | 32 | $299 | $9 |
| Lovastatin | 16 | $269 | $17 |
| Famotidine | 13 | $259 | $20 |
| Prednisone | 12 | $153 | $13 |
| Glipizide | 17 | $95 | $6 |
| Simvastatin | 20 | $69 | $3 |
| Cephalexin | 11 | $61 | $6 |
2019: 52 drugs
| Renvela | 43 | $135,764 | $3,157 |
| Sevelamer Carbonate | 108 | $57,628 | $534 |
| Veltassa | 46 | $40,579 | $882 |
| Procrit | 17 | $28,674 | $1,687 |
| Januvia | 15 | $20,345 | $1,356 |
| Prosol | 127 | $16,683 | $131 |
| Auryxia | 19 | $16,634 | $875 |
| Intralipid | 59 | $13,733 | $233 |
| Clinisol | 96 | $11,137 | $116 |
| Demeclocycline | 15 | $9,853 | $657 |
| Uloric | 14 | $9,663 | $690 |
| Febuxostat | 14 | $8,076 | $577 |
| Calcium Acetate | 43 | $7,391 | $172 |
| Vascepa | 14 | $6,123 | $437 |
| Omega-3 Acid Ethyl Esters | 26 | $5,298 | $204 |
| Spiriva | 11 | $5,035 | $458 |
| Dextrose in Water | 51 | $4,678 | $92 |
| Midodrine | 43 | $3,928 | $91 |
| Epogen | 16 | $3,881 | $243 |
| Potassium Chloride | 36 | $3,376 | $94 |
| Hydralazine | 108 | $2,643 | $24 |
| Olmesartan Medoxomil | 12 | $2,478 | $206 |
| Entecavir | 12 | $2,340 | $195 |
| Valsartan | 17 | $2,194 | $129 |
| Furosemide | 205 | $1,929 | $9 |
| Losartan | 152 | $1,674 | $11 |
| Allopurinol | 111 | $1,640 | $15 |
| Metoprolol | 36 | $1,568 | $44 |
| Amlodipine Besylate | 177 | $1,554 | $9 |
| Bumetanide | 14 | $1,488 | $106 |
| Ventolin Hfa | 23 | $1,378 | $60 |
| Atorvastatin | 72 | $1,197 | $17 |
| Calcitriol | 79 | $1,106 | $14 |
| Carvedilol | 70 | $925 | $13 |
| Pantoprazole | 54 | $737 | $14 |
| Gabapentin | 37 | $720 | $19 |
| Minoxidil | 12 | $658 | $55 |
| Metoprolol | 58 | $634 | $11 |
| Levothyroxine | 22 | $518 | $24 |
| Metolazone | 11 | $515 | $47 |
| Glimepiride | 53 | $494 | $9 |
| Hydrocodone-Acetaminophen | 11 | $415 | $38 |
| Clonidine | 25 | $401 | $16 |
| Pravastatin | 20 | $356 | $18 |
| Lovastatin | 17 | $338 | $20 |
| Lisinopril | 44 | $321 | $7 |
| Simvastatin | 23 | $215 | $9 |
| Sertraline | 13 | $214 | $16 |
| Omeprazole | 11 | $211 | $19 |
| Tamsulosin | 11 | $184 | $17 |
| Prednisone | 26 | $182 | $7 |
| Cephalexin | 19 | $69 | $4 |
2018: 46 drugs
| Renvela | 85 | $194,901 | $2,293 |
| Veltassa | 51 | $56,078 | $1,100 |
| Sevelamer Carbonate | 57 | $54,932 | $964 |
| Auryxia | 21 | $36,975 | $1,761 |
| Procrit | 15 | $22,962 | $1,531 |
| Clinisol | 165 | $21,389 | $130 |
| Uloric | 25 | $18,783 | $751 |
| Prosol | 119 | $16,548 | $139 |
| Januvia | 13 | $16,281 | $1,252 |
| Demeclocycline | 18 | $15,643 | $869 |
| Omega-3 Acid Ethyl Esters | 45 | $10,811 | $240 |
| Entecavir | 11 | $9,473 | $861 |
| Calcium Acetate | 36 | $4,485 | $125 |
| Potassium Chloride | 31 | $3,323 | $107 |
| Midodrine | 35 | $3,036 | $87 |
| Clonidine | 18 | $2,764 | $154 |
| Hydralazine | 90 | $2,558 | $28 |
| Intralipid | 11 | $2,545 | $231 |
| Furosemide | 240 | $2,254 | $9 |
| Losartan | 143 | $1,734 | $12 |
| Amlodipine Besylate | 158 | $1,624 | $10 |
| Prazosin | 19 | $1,600 | $84 |
| Valsartan | 19 | $1,382 | $73 |
| Allopurinol | 83 | $1,331 | $16 |
| Labetalol | 15 | $1,259 | $84 |
| Metoprolol | 22 | $1,177 | $53 |
| Pravastatin | 33 | $1,031 | $31 |
| Bumetanide | 18 | $936 | $52 |
| Glimepiride | 45 | $827 | $18 |
| Atorvastatin | 47 | $800 | $17 |
| Metoprolol | 86 | $711 | $8 |
| Calcitriol | 74 | $634 | $9 |
| Carvedilol | 64 | $634 | $10 |
| Pantoprazole | 46 | $632 | $14 |
| Levothyroxine | 18 | $624 | $35 |
| Gabapentin | 46 | $620 | $13 |
| Omeprazole | 13 | $411 | $32 |
| Diltiazem | 11 | $399 | $36 |
| Lactulose | 18 | $393 | $22 |
| Hydrocodone-Acetaminophen | 15 | $388 | $26 |
| Lidocaine-Prilocaine | 11 | $379 | $34 |
| Simvastatin | 28 | $329 | $12 |
| Lovastatin | 14 | $296 | $21 |
| Lisinopril | 30 | $247 | $8 |
| Prednisone | 20 | $175 | $9 |
| Levofloxacin | 16 | $75 | $5 |
2017: 44 drugs
| Renvela | 147 | $299,323 | $2,036 |
| Sensipar | 94 | $162,620 | $1,730 |
| Veltassa | 60 | $39,268 | $654 |
| Auryxia | 19 | $25,910 | $1,364 |
| Uloric | 31 | $21,372 | $689 |
| Clinisol | 127 | $20,229 | $159 |
| Januvia | 11 | $10,700 | $973 |
| Demeclocycline | 15 | $9,770 | $651 |
| Omega-3 Acid Ethyl Esters | 48 | $8,634 | $180 |
| Clonidine | 30 | $7,215 | $241 |
| Calcium Acetate | 25 | $3,752 | $150 |
| Prosol | 22 | $2,786 | $127 |
| Midodrine | 44 | $2,495 | $57 |
| Potassium Chloride | 20 | $2,371 | $119 |
| Hydralazine | 83 | $1,839 | $22 |
| Prazosin | 27 | $1,538 | $57 |
| Travasol | 18 | $1,454 | $81 |
| Allopurinol | 104 | $1,411 | $14 |
| Furosemide | 163 | $1,284 | $8 |
| Losartan | 127 | $1,200 | $9 |
| Amlodipine Besylate | 150 | $1,089 | $7 |
| Calcitriol | 82 | $1,077 | $13 |
| Atorvastatin | 37 | $929 | $25 |
| Pravastatin | 31 | $879 | $28 |
| Metoprolol | 12 | $838 | $70 |
| Glimepiride | 34 | $720 | $21 |
| Diltiazem | 16 | $598 | $37 |
| Minoxidil | 16 | $587 | $37 |
| Levothyroxine | 16 | $506 | $32 |
| Pantoprazole | 36 | $481 | $13 |
| Metoprolol | 77 | $443 | $6 |
| Hydrocodone-Acetaminophen | 17 | $394 | $23 |
| Carvedilol | 43 | $332 | $8 |
| Gabapentin | 35 | $296 | $8 |
| Lovastatin | 33 | $281 | $9 |
| Lactulose | 14 | $276 | $20 |
| Valsartan | 11 | $258 | $23 |
| Omeprazole | 20 | $219 | $11 |
| Lisinopril | 41 | $218 | $5 |
| Simvastatin | 28 | $198 | $7 |
| Clonidine | 22 | $181 | $8 |
| Prednisone | 17 | $175 | $10 |
| Warfarin | 12 | $160 | $13 |
| Levofloxacin | 26 | $136 | $5 |
2016: 43 drugs
| Renvela | 115 | $242,275 | $2,107 |
| Sensipar | 79 | $110,076 | $1,393 |
| Veltassa | 37 | $32,446 | $877 |
| Uloric | 47 | $23,459 | $499 |
| Januvia | 24 | $18,332 | $764 |
| Epogen | 16 | $17,042 | $1,065 |
| Procrit | 18 | $13,167 | $731 |
| Clinisol | 83 | $12,112 | $146 |
| Omega-3 Acid Ethyl Esters | 37 | $7,140 | $193 |
| Calcium Acetate | 37 | $5,177 | $140 |
| Midodrine | 33 | $2,654 | $80 |
| Lidocaine-Prilocaine | 19 | $2,327 | $122 |
| Potassium Chloride | 22 | $2,127 | $97 |
| Hydralazine | 75 | $2,093 | $28 |
| Allopurinol | 114 | $1,759 | $15 |
| Losartan | 137 | $1,732 | $13 |
| Calcitriol | 87 | $1,642 | $19 |
| Amlodipine Besylate | 164 | $1,558 | $10 |
| Atorvastatin | 44 | $1,465 | $33 |
| Prazosin | 21 | $1,275 | $61 |
| Furosemide | 165 | $1,262 | $8 |
| Tamsulosin | 14 | $1,239 | $89 |
| Pravastatin | 44 | $1,113 | $25 |
| Metoprolol | 74 | $972 | $13 |
| Levothyroxine | 28 | $951 | $34 |
| Carvedilol | 60 | $641 | $11 |
| Glimepiride | 33 | $605 | $18 |
| Metoprolol | 11 | $506 | $46 |
| Hydrocodone-Acetaminophen | 13 | $479 | $37 |
| Valsartan | 23 | $463 | $20 |
| Clopidogrel | 13 | $420 | $32 |
| Lovastatin | 34 | $404 | $12 |
| Levofloxacin | 41 | $372 | $9 |
| Clonidine | 35 | $364 | $10 |
| Simvastatin | 28 | $361 | $13 |
| Warfarin | 17 | $342 | $20 |
| Lisinopril | 47 | $340 | $7 |
| Pantoprazole | 26 | $328 | $13 |
| Gabapentin | 34 | $306 | $9 |
| Famotidine | 20 | $247 | $12 |
| Omeprazole | 24 | $239 | $10 |
| Prednisone | 14 | $177 | $13 |
| Atenolol | 13 | $103 | $8 |
2015: 40 drugs
| Renvela | 119 | $199,167 | $1,674 |
| Sensipar | 60 | $54,935 | $916 |
| Januvia | 35 | $21,626 | $618 |
| Uloric | 46 | $20,858 | $453 |
| Procrit | 20 | $16,440 | $822 |
| Omega-3 Acid Ethyl Esters | 47 | $8,836 | $188 |
| Epogen | 13 | $6,311 | $485 |
| Clinisol | 46 | $5,123 | $111 |
| Calcium Acetate | 31 | $3,768 | $122 |
| Humalog Kwikpen U-100 | 14 | $3,416 | $244 |
| Midodrine | 32 | $2,379 | $74 |
| Lidocaine-Prilocaine | 13 | $2,371 | $182 |
| Hydralazine | 95 | $2,071 | $22 |
| Calcitriol | 80 | $2,009 | $25 |
| Prazosin | 28 | $1,918 | $68 |
| Allopurinol | 109 | $1,519 | $14 |
| Pravastatin | 34 | $1,224 | $36 |
| Losartan | 110 | $1,180 | $11 |
| Furosemide | 158 | $1,084 | $7 |
| Atorvastatin | 36 | $1,078 | $30 |
| Amlodipine Besylate | 122 | $944 | $8 |
| Tamsulosin | 18 | $940 | $52 |
| Levothyroxine | 23 | $759 | $33 |
| Valsartan | 13 | $684 | $53 |
| Metoprolol | 25 | $579 | $23 |
| Glimepiride | 30 | $560 | $19 |
| Carvedilol | 65 | $544 | $8 |
| Isosorbide Dinitrate | 13 | $434 | $33 |
| Metoprolol | 48 | $347 | $7 |
| Simvastatin | 52 | $313 | $6 |
| Amiodarone | 20 | $279 | $14 |
| Pantoprazole | 15 | $271 | $18 |
| Warfarin | 17 | $264 | $16 |
| Gabapentin | 35 | $259 | $7 |
| Clonidine | 20 | $255 | $13 |
| Lovastatin | 14 | $242 | $17 |
| Levofloxacin | 17 | $214 | $13 |
| Lisinopril | 28 | $162 | $6 |
| Famotidine | 20 | $149 | $7 |
| Azithromycin | 14 | $81 | $6 |
2014: 42 drugs
| Renvela | 114 | $135,962 | $1,193 |
| Sensipar | 54 | $39,365 | $729 |
| Sevelamer Carbonate | 17 | $17,504 | $1,030 |
| Uloric | 26 | $10,648 | $410 |
| Januvia | 20 | $9,256 | $463 |
| Diovan | 33 | $8,608 | $261 |
| Lovaza | 29 | $6,397 | $221 |
| Aggrenox | 17 | $4,017 | $236 |
| Omega-3 Acid Ethyl Esters | 11 | $2,878 | $262 |
| Calcitriol | 83 | $2,670 | $32 |
| Hydralazine | 83 | $2,087 | $25 |
| Losartan | 124 | $1,979 | $16 |
| Midodrine | 21 | $1,475 | $70 |
| Calcium Acetate | 16 | $1,282 | $80 |
| Lidocaine-Prilocaine | 13 | $1,268 | $98 |
| Prazosin | 21 | $1,209 | $58 |
| Furosemide | 166 | $1,191 | $7 |
| Pravastatin | 37 | $1,107 | $30 |
| Amlodipine Besylate | 132 | $1,052 | $8 |
| Metoprolol | 26 | $811 | $31 |
| Tamsulosin | 26 | $777 | $30 |
| Carvedilol | 68 | $731 | $11 |
| Allopurinol | 94 | $717 | $8 |
| Atorvastatin | 27 | $623 | $23 |
| Levothyroxine | 21 | $551 | $26 |
| Diltiazem 24hr Er | 11 | $545 | $50 |
| Simvastatin | 57 | $512 | $9 |
| Pantoprazole | 22 | $321 | $15 |
| Isosorbide Dinitrate | 11 | $320 | $29 |
| Metoprolol | 50 | $312 | $6 |
| Megestrol Acetate | 16 | $298 | $19 |
| Minoxidil | 16 | $276 | $17 |
| Clonidine | 27 | $263 | $10 |
| Famotidine | 36 | $247 | $7 |
| Lisinopril | 24 | $247 | $10 |
| Lovastatin | 16 | $228 | $14 |
| Glimepiride | 32 | $218 | $7 |
| Gabapentin | 37 | $204 | $6 |
| Levofloxacin | 22 | $202 | $9 |
| Glipizide Er | 15 | $147 | $10 |
| Prednisone | 18 | $118 | $7 |
| Donepezil | 18 | $103 | $6 |
2013: 36 drugs
| Renvela | 102 | $97,346 | $954 |
| Sensipar | 32 | $19,899 | $622 |
| Uloric | 41 | $15,787 | $385 |
| Procrit | 19 | $8,727 | $459 |
| Diovan | 26 | $7,050 | $271 |
| Lovaza | 33 | $6,232 | $189 |
| Clinisol | 21 | $4,310 | $205 |
| Losartan | 114 | $2,629 | $23 |
| Labetalol | 26 | $1,901 | $73 |
| Calcium Acetate | 14 | $1,868 | $133 |
| Amlodipine Besylate | 148 | $1,531 | $10 |
| Calcitriol | 73 | $1,510 | $21 |
| Hydralazine | 47 | $1,462 | $31 |
| Carvedilol | 85 | $1,241 | $15 |
| Metoprolol | 32 | $1,085 | $34 |
| Prazosin | 35 | $916 | $26 |
| Furosemide | 131 | $841 | $6 |
| Atorvastatin | 22 | $809 | $37 |
| Simvastatin | 55 | $512 | $9 |
| Pantoprazole | 35 | $503 | $14 |
| Allopurinol | 80 | $493 | $6 |
| Lisinopril | 37 | $428 | $12 |
| Pravastatin | 22 | $389 | $18 |
| Metoprolol | 56 | $366 | $7 |
| Tamsulosin | 17 | $331 | $19 |
| Megestrol Acetate | 14 | $330 | $24 |
| Clonidine | 32 | $281 | $9 |
| Minoxidil | 18 | $270 | $15 |
| Levofloxacin | 22 | $233 | $11 |
| Levothyroxine | 15 | $166 | $11 |
| Gabapentin | 13 | $134 | $10 |
| Donepezil | 22 | $133 | $6 |
| Prednisone | 34 | $128 | $4 |
| Glipizide | 16 | $86 | $5 |
| Warfarin | 14 | $75 | $5 |
| Famotidine | 12 | $68 | $6 |
Money from drug and device companies
$122 in 2025
| 2025 | 2 | 2 | None | $122 |
| 2021 | 1 | 1 | None | $20 |
| 2020 | 1 | 1 | None | $23 |
| 2019 | 12 | 45 | None | $701 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Apellis Pharmaceuticals | None | $108 | 1 payment
|
| Novo Nordisk | None | $14 | 1 payment
|
See all 2 published payments
| Apellis Pharmaceuticals | Meals · 2025-11-20 | None | $108 |
| Novo Nordisk | Meals · 2025-09-24 | None | $14 |
See earlier years (2021, 2020, 2019)
2021: $20
| Bayer HealthCare Pharmaceuticals | Kerendia | $20 | 1 payment
|
2020: $23
| Astellas Pharma US | Lexiscan | $23 | 1 payment
|
2019: $701
| Relypsa | Veltassa | $138 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $131 | 8 payments
|
| Akebia Therapeutics | Auryxia | $90 | 5 payments
|
| Amgen | Aranesp | $89 | 4 payments
|
| Fresenius USA Marketing | Velphoro | $52 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $45 | 3 payments
|
| Alexion Pharmaceuticals | Soliris | $43 | 2 payments
|
| Genzyme | Fabry-Disease | $27 | 2 payments
|
| Allergan | Vraylar | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $20 | 1 payment
|
| Amarin Pharma | Vascepa | $19 | 1 payment
|
Professional record
- NPI
- 1366630444
- Licence
- CA A93552California A93552: Current · expires 2027-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 200 Jose Figueres Ave, Suite 255, San Jose, CA, 95116
- NPI first listed
- 2007-10-14
- NPI last updated
- 2014-01-23
This is when the NPI record was last certified, not a medical board exam.